Since A2A and A2B adenosine receptors regulate glucose homeostasis in diabetes and obesity ligands of these receptors may be useful for the prevention and treatment of obesity-associated metabolic disorders. The gene discussed is IGKV2D-29; the disease is obesity disorder.